Echosens

Echosens is a pioneer in non-invasive liver health assessment, headquartered in Westborough, Massachusetts. The company manufactures and distributes FibroScan®, the global reference standard for liver fibrosis and liver steatosis assessment. FibroScan® uses Vibration-Controlled Transient Elastography (VCTE) technology to enable non-invasive, painless evaluation of liver disease without biopsy. With over 6,500 systems installed worldwide across 127+ countries, Echosens has facilitated millions of liver examinations. The technology is supported by over 6,270 peer-reviewed publications and recognition in 250+ international clinical guidelines. Echosens offers multiple product lines: the FibroScan® Family (including FibroScan® Mini, a portable variant); Guided VCTE™ (next-generation assessment platform); Liver Health Management (LHM), a cloud-based solution for comprehensive liver disease monitoring; and Scores solutions that integrate biological markers with FibroScan® data. The company serves hepatology, gastroenterology, infectious disease, primary care, and occupational health settings. Echosens manufactures devices with uniform algorithms designed to minimize inter-operator variability and eliminate inter-system variability, supporting evidence-based clinical decision-making. The company operates a global distribution network and provides trade-in programs for equipment upgrades.